In September 2022 United Kingdom Anti-Doping (UKAD) has reported an anti-doping rule violation against the rugby player Robert Oakley after his sample tested positive for the prohibited substances Enobosarm (Ostarine), GW1516, LGD-4033 (Ligandrol) and RAD140.
Following notification the Athlete gave a prompt admission, waived his right for a hearing, accepted a provisional suspension and the sanction proposed by UKAD. He stated that he had used Ostarine tablets he had purchased on the internet.
He explained that the Ostarine was used to recover from his injury and that he was unaware that Ostarine was a prohibited substance. He assumed that the other substances must have been contained in the Ostarine tablets he had used.
UKAD deemed that the violation was intentional and considers that the Athlete shall receive a 1 year reduction to the period of ineligibility for his timely admission of the anti-doping rule violation.
Therefore on 13 February 2023 UKAD decides to impose a 3 year period of ineligibility on the Athlete, starting backdated on the date of the provisional suspension, i.e. on 6 September 2022.
